pcnindiaglobal
October 8, 2026October 12, 2026
CDSCO, Compliance Guides, Import Compliance, Medical Devices

CDSCO Licence for HIV Test Kits in India: Class D IVD Registration and Process

An HIV test kit detects antibodies or antigens to HIV, and the consequence of a wrong result — for the individual and, in blood screening, for a transfusion recipient — is severe. In fact, that is why CDSCO regulates HIV test kits as a Class D in-vitro diagnostic (IVD), the highest IVD risk tier, with a rigorous performance-evaluation report behind the licence. This guide covers the full CDSCO registration pathway for HIV test kits under the Medical Devices Rules, 2017 — classification, licence route, the performance evidence, the documents, the fees and the timeline. This guide explains CDSCO registration for hiv test kits in India — risk class, licence forms, standards, documents, fees and timeline.

Is a CDSCO Registration Mandatory for HIV Test Kits?

Yes. Furthermore, an HIV test kit is a notified in-vitro diagnostic and cannot be manufactured, imported or sold in India without a CDSCO licence. Because HIV detection is Class D, a domestic manufacturer applies to the Central Licensing Authority in Form MD-7 for a Form MD-9 licence, and an importer applies in Form MD-14 for a Form MD-15 import licence. Also, in India, HIV-kit performance evaluation is carried out at designated referral laboratories.

Risk Classification of HIV Test Kits

Every medical device in India falls into one of four risk classes (A, B, C, D) under the First Schedule of the Medical Devices Rules, 2017. Moreover, the class fixes the authority, the form, the fee, the audit route and the timeline.

In addition, HIV Test Kits are classified as Class D (high risk). An IVD that detects an infectious agent (HIV) where an incorrect result poses a significant risk to the individual and to public/transfusion safety is classified at Class D under the IVD classification rules — kits detecting transmissible agents of life-threatening disease with a high risk of propagation, such as HIV, sit in the highest IVD class. Confirm against the current CDSCO classification list for your exact kit. Also, where a device could fall in two classes the higher class applies, and an accessory is classified in its own right. Always confirm against the current CDSCO classification list.

Which CDSCO Licence You Need for HIV Test Kits

To manufacture HIV test kits in India (Class D) — apply in Form MD-7 to the Central Licensing Authority (CDSCO headquarters). The licensing authority grants the licence in Form MD-9. A CDSCO joint audit team inspects the manufacturing site before the licensing authority grants the licence — site inspection is mandatory for Class C and D.
To import HIV test kits (any class) — the overseas manufacturer appoints an Indian Authorised Agent who files Form MD-14 with the Central Licensing Authority; CDSCO grants the import licence in Form MD-15.
Test licence — for a small quantity imported or made for testing, evaluation, demonstration or clinical investigation: Form MD-12 application, Form MD-13 licence.
Loan licence — using another licensee’s approved premises: Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a licence in Form MD-6 or MD-10.

Applicable Standards for HIV Test Kits

HIV test kits are evaluated principally on their performance evidence, supported by IVD quality and labelling standards:

Performance Evaluation Report (PER) — analytical and clinical sensitivity and specificity against reference panels, at a CDSCO-designated evaluation laboratory.
ISO 13485 — quality management system for the IVD manufacturer.
ISO 23640 — stability evaluation of the IVD reagents (kit shelf-life).
ISO 14971 — risk management, including false-negative/false-positive consequences.
ISO 18113 — IVD labelling and information supplied by the manufacturer.
WHO prequalification / reference-panel evidence where available, to support performance.

Documents Required for CDSCO Registration of HIV Test Kits

Whether you file for a manufacturing or an import licence, CDSCO expects the same core technical dossier built around the device:

Covering letter and application form — Form MD-3 / MD-7 (manufacture) or Form MD-14 (import) on the CDSCO Medical Device Online portal, stating every device, variant and site.
Device Master File (DMF) — device description and intended use, materials, design and manufacturing information, ISO 14971 risk file, verification/validation data, sterilisation validation where applicable, shelf-life/stability data and the Essential Principles checklist.
Plant Master File (PMF) — site layout, equipment, utilities/HVAC, organisation chart with competent technical staff and the QMS procedures governing production.
ISO 13485 QMS certificate — current, with a scope covering the device.
Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable principle with the standard/evidence relied on.
Risk management file (ISO 14971) — hazards, risk controls and residual-risk justification.
Test / performance reports — against the applicable BIS/IS or ISO/IEC standards from an accredited laboratory.
Labels, IFU and packaging — meeting the labelling requirements of the Medical Devices Rules (manufacturer, licence number, sterile status, single-use symbols).
Undertaking and declaration of conformity to the Essential Principles and applicable standards.
Government fee receipt — paid online through the CDSCO portal.

Device-Specific Documents for HIV Test Kits

Device-specific documents on top of the core set for HIV test kits:

Performance Evaluation Report from a CDSCO-designated referral laboratory — sensitivity, specificity and reproducibility.
Reference-panel results including seroconversion panels where applicable.
Stability (ISO 23640) data — kit shelf-life and transport stability.
Cut-off determination and cross-reactivity evidence.
Lot-to-lot consistency data.
Country-of-origin approval / Free Sale Certificate for imports.

For an import licence (Form MD-14) there are three further essentials:

Free Sale Certificate (FSC) — from the National Regulatory Authority of the country of origin, legalised (apostille/embassy attestation).
Country-of-origin regulatory approval — US FDA 510(k)/PMA, EU CE certificate or equivalent.
Power of Attorney and Authorised Agent licence — notarised, legalised PoA to the Indian Authorised Agent, plus the agent’s valid wholesale/manufacturing licence.

QMS & Essential Principles — What CDSCO Checks

Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible. Shown through recognised standards and the risk-management file.
Quality Management System (ISO 13485) — design controls, supplier control, process validation, traceability, complaint handling and CAPA, evidenced at audit.
Risk management (ISO 14971) — a living file with residual risks justified and communicated in the IFU.
Clinical evidence — proportionate to the class: clinical evaluation for lower-risk devices and clinical investigation data for many Class C/D and novel devices.

Label & IFU Requirements Specific to HIV Test Kits

IVD labelling (ISO 18113) is checked closely for lot, expiry and intended-use information:

Product name, IVD symbol, the analyte (HIV-1/2, antigen/antibody) and intended use.
Manufacturer name and address, and the CDSCO licence number.
Lot/batch number, date of manufacture and expiry date.
Storage conditions and specimen type.
A clear statement on confirmatory testing and result interpretation in the IFU.

Screening, Diagnostic or Self-Test, and the Referral-Lab Step

HIV kits differ by intended use — blood-donor screening, diagnostic testing and self-testing — and the intended use shapes the evidence and the exact class, so confirm it against the current CDSCO IVD list. Additionally, what is common to HIV kits in India is the mandatory performance evaluation at a designated referral laboratory before the licence issues; you cannot self-certify performance. Build the referral-lab evaluation into your timeline from the start, because it is on the critical path.

Step-by-Step CDSCO Registration Process for HIV Test Kits

Confirm the classification. Fix the risk class against the CDSCO classification list and the First Schedule — Class D here — which decides the form, authority, fee and audit route.
Choose the route. Manufacture (Form MD-7 → MD-9) or import (Form MD-14 → MD-15). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
Build the Device Master File and Plant Master File. Assemble device description, materials, design and process data, the ISO 14971 risk file, sterilisation/stability data and the site file with the QMS.
Complete the Essential Principles checklist. Map the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on.
Draw the test and performance reports. Test to the applicable standards at an accredited laboratory. Sterile and measuring devices carry additional validation.
Register and file on the CDSCO Medical Device Online portal. Create the account, pay the government fee online and upload the full dossier under the correct form.
Site audit / inspection. A CDSCO joint audit team inspects the manufacturing site before the licensing authority grants the licence — site inspection is mandatory for Class C and D.
Respond to queries and receive the licence. Answer the deficiency letter within the stipulated period. On approval the licence issues in Form MD-9 (manufacture) or MD-15 (import).

CDSCO Registration Fees and Timeline for HIV Test Kits

The Second Schedule of the Medical Devices Rules sets the fees, and you pay them online through the CDSCO portal. Also, for manufacture of a Class D device the fee is Rs 50,000 per site plus Rs 1,000 for each distinct device, paid to the Central Licensing Authority (CDSCO headquarters). CDSCO charges import fees under Form MD-15 per site and per device in USD — roughly USD 1,000 per site plus USD 50 per device for lower-risk devices, up to about USD 3,000 per site plus USD 1,500 per device for Class C and D. In fact, a test licence (Form MD-13) carries a modest fee. Always confirm the current figure on the CDSCO portal before filing.

Furthermore, a complete Class D manufacturing file typically clears in about six to nine months. An import (MD-15) file usually takes six to nine months. Also, every deficiency letter effectively restarts the clock. Unlike the old registration certificates, an MDR 2017 licence does not expire — it stays valid as long as you pay the retention fee (equal to the licence fee) every five years and meet the conditions of licence.

Common Mistakes That Trigger a CDSCO Query

Common query reasons for HIV-kit IVD applications are:

Performance data not from a CDSCO-designated referral laboratory, or below the required sensitivity/specificity.
Missing seroconversion-panel or reproducibility data.
Stability data not supporting the labelled shelf-life.
IVD labelling missing the analyte, lot or IVD symbol per ISO 18113.
Free Sale Certificate scope not covering the exact kit on import.

Related Approvals to Plan Alongside CDSCO

DGFT Importer-Exporter Code — mandatory for any importer of record before the first consignment.
Wholesale / sale licence (Form 20B/21B or Form MD-42) — for stocking and distributing the device. The Indian Authorised Agent for an import licence must already hold one.
Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme.

Post-Approval Obligations

Print the licence number on the label and keep the Essential Principles conformity current.
Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device’s class.
Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country.
Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

FAQs on CDSCO Registration for HIV Test Kits

What CDSCO class is an HIV test kit?

An HIV test kit is a Class D IVD, so a domestic manufacturer files Form MD-7 for an MD-9 licence with the Central Licensing Authority, and an importer files Form MD-14 for an MD-15 licence.

Is referral-laboratory evaluation mandatory for HIV kits?

Yes — HIV-kit performance is evaluated at a CDSCO-designated referral laboratory before the licence issues, so plan for that step on the critical path.

What performance evidence does CDSCO expect?

Sensitivity, specificity and reproducibility against reference panels (including seroconversion panels where applicable), with stability and cut-off/cross-reactivity data.

Do IVDs use different forms?

No — IVDs use the same MDR 2017 forms (MD-9 for Class D manufacture, MD-15 for import). Moreover, the distinguishing requirement is the performance-evaluation evidence.

How long does HIV-kit registration take?

Budget beyond the usual six to nine months where the referral-laboratory evaluation adds time. In addition, a complete file plus evaluation should be planned generously.

Does the licence expire?

No — the MDR 2017 licence is perpetual, subject to the five-yearly retention fee and continued compliance.

Related CDSCO Registration Guides

Need end-to-end help? See our CDSCO registration services, or read these related guides:

Official references: Central Drugs Standard Control Organisation (CDSCO) and the CDSCO MD Online portal.

Why Choose PCN India Global

Classification triage — we confirm the correct risk class for your HIV test kits against the current CDSCO list before we draft anything.
Route selection — manufacture (MD-5/MD-9) or import (MD-15), with the Indian Authorised Agent arrangement handled.
Dossier build — Device Master File, Plant Master File, Essential Principles checklist and ISO 13485/ISO 14971 readiness.
Standards and testing — the right BIS/IS or ISO/IEC standards mapped and accredited test reports coordinated.
End-to-end online filing — application, audit support, query response and the licence grant managed for you.
Adjacent approvals — DGFT/IEC, LMPC, wholesale/sale licence and BIS coordinated alongside your CDSCO licence.

PCN India Global manages the complete CDSCO process for HIV test kits — from classification and route selection to Device and Plant Master File preparation, online filing, audit support and the licence grant. Also, whatsapp or call +91 80109 05029, or email admin@pcnindiaglobal.com, to get your registration underway.

Related Compliance Guides

CDSCO Licence for Coronary Stents
CDSCO Registration for Syringes
CDSCO Licence for Surgical Gloves
CDSCO Licence for Ventilators